Canada says it will continue with its rollout of the AstraZeneca vaccine despite concerns about a link between shots and blood clots in Europe.
Canadian Prime Minister Justin Newdew said during a news report, “Obviously we are following what is happening in Europe with a specific batch, but I can assure all Canadians that any dose of AstraZeneca is the same. Batch has not met, causing concern in Europe. Conference in Montreal.
Health Canada confirmed last week that it is aware of reports of adverse events in Europe after being vaccinated with the AstraZeneca Kovid-19 vaccine, but said “the benefits of the vaccine continue to outweigh its risks.”
“At this time, there is no indication that the vaccine caused these events. To date, no adverse events related to the AstraZeneca COVID-19 vaccine, or the version produced by the Serum Institute of India, have been reported to Health Canada or the Public Health Agency of Canada, “in a statement posted last week Having said.
“The best vaccine for you is the first vaccine you are given,” Trudeau said on Monday.
Canada’s vaccine regulator approved the AstraZeneca shot at the end of last month, and approved it for all Canadian citizens over the age of 18. However, the Canadian National Advisory Committee chose not to recommend Vaccination (NACI) to AstraZeneca’s vaccine for people 65 and older, as it called an insufficient amount of evidence for that age group.
The Canadian provinces responsible for the vaccine have adopted slightly different methods, with the AstraZeneca vaccine banned to those under 65 years of age.
Earlier on Monday, Trudeau visited a large-scale vaccination site in the city of Montreal, a city that remains a stubborn attraction for coronovirus infections.
Trudeau said he felt relieved to see his mother getting vaccinated in recent times, even though he has no firm date to take his vaccine shot.
“When my turn comes, I will not focus on it.” When it arrives, I will gladly get vaccinated but I will wait for my turn, ”he said.